The continuous glucose monitoring system can be used to measure glucose levels in adults with diabetes for up to six months.
A study published in JAMA Network Open found CCBT led to improved depressive symptoms in primary care patients compared with treatment as usual alone.
The Egyptian non-profit has teamed up with GE Healthcare to utilise AI to assess how well a patient is responding to neoadjuvant therapy, commonly used prior to surgery.
